These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4603511)

  • 1. [Effects of pyridoxylate in patients with severe cerebral arteriosclerosis (results of a double blind trial)].
    Cottin S; Prost A; Lefevre M; Auvinet B
    Sem Hop Ther; 1974 Jan; 50(1):41-4. PubMed ID: 4603511
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of pyridoxylate in long term anoxia].
    Prigent C; Macher M; Macher JP
    Nouv Presse Med; 1972 Jan; 1(1):51-2. PubMed ID: 4551400
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of pyrithioxine combined with a vasodilator in patients with cerebral arteriosclerosis].
    Schlesinger P
    Rev Bras Med; 1972 Jan; 29(1):38-41. PubMed ID: 4552863
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experimentation with pyridoxylate in treatment of various chorioretinal degenerative disorders (50 cases)].
    Boudet C; Philippot M; Arnaud B
    Bull Soc Ophtalmol Fr; 1969 Dec; 69(12):1145-50. PubMed ID: 5402204
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind trial of naftidrofuryl in the treatment of cerebral arteriosclerosis.
    Gerin J
    Br J Clin Pract; 1974 May; 28(5):177-8. PubMed ID: 4604345
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of pyridoxylate on the arterio-venous differences of O2 and CO2 in the brain].
    Espagno J; Arbus L; Lazorthes Y; Viallard G
    Therapeutique; 1970 Oct; 46(8):777-80. PubMed ID: 5458908
    [No Abstract]   [Full Text] [Related]  

  • 7. [The clinical applications in opthalmology of an original factor in cellular nutrition (piridoxylate].
    Verin P; Sekkat A; Lagoutte F
    Arch Ophtalmol Rev Gen Ophtalmol; 1974 Jan; 34(1):65-74. PubMed ID: 4278378
    [No Abstract]   [Full Text] [Related]  

  • 8. Manifestations of cerebral arteriosclerosis unaffected by a vasodilator.
    Practitioner; 1969 Nov; 203(217):695-8. PubMed ID: 4391604
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of pentetrazole on serum cholesterol level and on behavior of patients with cerebral arteriosclerosis].
    Merkus JW
    Ned Tijdschr Geneeskd; 1968 Sep; 112(37):1634-8. PubMed ID: 4878453
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of thyroidin in combination with vitamins C, B-6 and B-12 in cerebral arteriosclerosis].
    Komorovskaia IaM
    Vrach Delo; 1965 May; 5():54-9. PubMed ID: 5854497
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
    Reimann-Hunziker R; Reimann-Hunziker GJ
    Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term anticoagulant therapy in patients with cerebral infarction. A crontrolled clinical study.
    Enger E; Boyesen S
    Acta Med Scand Suppl; 1965; 438():1-61. PubMed ID: 5323519
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.
    Thibault A
    Curr Med Res Opin; 1974; 2(8):482-7. PubMed ID: 4217240
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind study of the effect of ribonucleic acid in senile brain disease.
    Nodine JH; Shulkin MW; Slap JW; Levine M; Freiberg K
    Am J Psychiatry; 1967 Apr; 123(10):1257-9. PubMed ID: 5336625
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of pyridoxilate on the microcirculation in diabetics].
    Le Goff Y; Gerard R; Argemi B; Casalonga J; Simonin R
    Mars Med; 1971; 108(4):277-81. PubMed ID: 5563026
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glyo-syz in the treatment of chronic coronary insufficiency].
    Miasnikov LA; Metelitsa VI; Dubinina LT
    Ter Arkh; 1971 Jul; 43(7):60-2. PubMed ID: 5149763
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical effects of circuletin-F on peripheral circulation disorders in essential hypertension and cerebral arteriosclerosis -- study by a double-blind method].
    Tahara T; Yoshisaka K
    Horumon To Rinsho; 1975 Mar; 23(3):265-72. PubMed ID: 1102155
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the treatment of cerebral nutrition disorders. A double blind study].
    Kirchberger F; Kehl R; Gutmann W
    Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the treatment of early symptoms of presclerosis. Experience with Instenon in a blind study].
    Kandziora J
    Med Klin; 1971 Jun; 66(24):889-91. PubMed ID: 4931691
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of cerebral insufficiency].
    Grill P; Broicher H
    Dtsch Med Wochenschr; 1969 Nov; 94(47):2429-35. PubMed ID: 4981669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.